(Q53377005)
Statements
A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. (English)
1 reference
X A Alvarez
1 reference
R Cacabelos
1 reference
M Laredo
1 reference
V Couceiro
1 reference
C Sampedro
1 reference
M Varela
1 reference
L Corzo
1 reference
L Fernandez-Novoa
1 reference
M Vargas
1 reference
M Aleixandre
1 reference
C Linares
1 reference
E Granizo
1 reference
D Muresanu
1 reference
H Moessler
1 reference
1 January 2006
1 reference
13
1 reference
43-54
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference